Skip to content
Our Company
Overview
Team
Collaborators
In Memoriam
Technology
Overview
The Vaccine Platform
Viral Hemorrhagic Fever Vaccines Pipeline
Emerging & Re-emerging Disease Vaccines
Medical Counter Measures
Proteins & Adjuvants
Newsroom
Contact
Cookie Policy
Privacy Policy
Terms of Use
HTDC Awards More Than $3 Million in Grants to Hawaii Companies
Post navigation
Previous:
Soligenix Announces Presentation of Positive Preliminary Results of a Heat Stable Formulation of Hawaii Biotech Ebola Vaccine
Next:
Hawaii Biotech Opens New State-of-the-art R&D Laboratories and Headquarters
